N-[2-[3-(aminomethyl)-5-(trifluoromethyl)anilino]-2-oxoethyl]-3-cyclopentylpropanamide;hydrochloride
C18H25ClF3N3O2 — CID 120604730
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[3-(aminomethyl)-5-(trifluoromethyl)anilino]-2-oxoethyl]-3-cyclopentylpropanamide;hydrochloride
N-[2-[3-(aminomethyl)-5-(trifluoromethyl)anilino]-2-oxoethyl]-3-cyclopentylpropanamide;hydrochloride (PubChem CID 120604730) has the molecular formula C18H25ClF3N3O2 and a molecular weight of 407.86 g/mol. Its IUPAC name is N-[2-[3-(aminomethyl)-5-(trifluoromethyl)anilino]-2-oxoethyl]-3-cyclopentylpropanamide;hydrochloride.
Molecular Properties
| Compound Name | N-[2-[3-(aminomethyl)-5-(trifluoromethyl)anilino]-2-oxoethyl]-3-cyclopentylpropanamide;hydrochloride |
|---|---|
| PubChem CID | 120604730 |
| Molecular Formula | C18H25ClF3N3O2 |
| Molecular Weight | 407.86 g/mol |
| Exact Mass | 407.16 |
| IUPAC Name | N-[2-[3-(aminomethyl)-5-(trifluoromethyl)anilino]-2-oxoethyl]-3-cyclopentylpropanamide;hydrochloride |
| SMILES | Cl.NCc1cc(NC(=O)CNC(=O)CCC2CCCC2)cc(C(F)(F)F)c1 |
| InChI | InChI=1S/C18H24F3N3O2.ClH/c19-18(20,21)14-7-13(10-22)8-15(9-14)24-17(26)11-23-16(25)6-5-12-3-1-2-4-12;/h7-9,12H,1-6,10-11,22H2,(H,23,25)(H,24,26);1H |
| InChIKey | ZQHKZNNPNPSMBD-UHFFFAOYSA-N |
| XLogP | 3.61 |
| TPSA | 84.22 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 407.86 |
| LogP ≤ 5 | 3.61 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120604730 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.